Jevalent, I am not happy...But do see a bright future...This is a turnaround situation...
The. Main objective of the CEO and Board is to grow shareholder wealth......
That will happen next year...The deals are all happening post PH2 trials... This OXYMORPHONE patch will be very valuable...
But until then disappointment from long term shareholders will weigh heavily.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.28M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.437K | 313.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 24165599 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 28082733 | 24 |
View Market Depth
| Last trade - 15.41pm 28/07/2025 (20 minute delay) ? |
| AVE (ASX) Chart |